Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy

被引:110
作者
Erdmann, J
Raible, J
Maki-Abadi, J
Hummel, M
Hammann, J
Wollnik, B
Frantz, E
Fleck, E
Hetzer, R
Regitz-Zagrosek, V
机构
[1] Humboldt Univ, Campus Virchow Klinikum, Charite, Dept Internal Med, D-13353 Berlin, Germany
[2] Humboldt Univ, Campus Virchow Klinikum, Charite, Dept Cardiol, D-13353 Berlin, Germany
[3] Deutesch Herzzentrum, Berlin, Germany
[4] Univ Istanbul, Inst Child Hlth, Dept Med Genet, Istanbul, Turkey
关键词
D O I
10.1016/S0735-1097(01)01387-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We studied the clinical and genetic features of hypertrophic cardiomyopathy (HCM) caused by mutations in the myosin-binding protein C gene (MYBPC3) in 110 consecutive, unrelated patients and family members of European descent. Background Mutations in the MYBPC3 gene represent the cause of HCM in similar to 15% of familial cases. MYBPC3 mutations were reported to include mainly nonsense versus missense mutations and to be characterized by a delayed onset and benign clinical course of the disease in Japanese and French families. We investigated the features that characterize MYBPC3 variants in a large, unrelated cohort of consecutive patients. Methods The MYBPC3 gene was screened by single-strand conformational polymorphism analysis and sequencing. The clinical phenotypes were analyzed using rest and 24-h electrocardiography, electrophysiology, two-dimensional and Doppler echocardiography and angiography. Results We identified 13 mutations in the: MYBPC3 gene: one nonsense, four missense and three splicing mutations and five small deletions and insertions. Of these, 11 were novel, and two were probably founder mutations. Patients with MYBPC3 mutations presented a broad range of phenotypes. In general the 16 carriers of protein truncations had a tendency toward earlier disease manifestations (33 +/- 13 vs. 48 +/-9 years; p = 0.06) and more frequently needed invasive procedures (septal ablation or cardioverter-defibrillator implantation) compared with the 9 carriers of missense mutations or in-frame deletions (12/16 vs. 1/9 patients; p < 0.01). Conclusions Multiple mutations, which include missense, nonsense and splicing mutations, as well as small deletions and insertions, occur in the MYBPC3 gene. Protein truncation mutations seem to cause a more severe disease phenotype than missense mutations or in-frame deletions. (J Am Coll Cardiol 2001;38:322-30) (C) 2001 by the American College of Cardiology.
引用
收藏
页码:322 / 330
页数:9
相关论文
共 31 条
  • [21] The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: A unique profile of both independent and founder events
    Moolman-Smook, JC
    De Lange, WJ
    Bruwer, ECD
    Brink, PA
    Corfield, VA
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (05) : 1308 - 1320
  • [22] Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy
    Niimura, H
    Bachinski, LL
    Sangwatanaroj, S
    Watkins, H
    Chudley, AE
    McKenma, W
    Kristinsson, A
    Roberts, R
    Sole, M
    Maron, BJ
    Seidman, JG
    Seidman, CE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (18) : 1248 - 1257
  • [23] Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy - Characterization of cardiac transcript and protein
    Rottbauer, W
    Gautel, M
    Zehelein, J
    Labeit, S
    Franz, WM
    Fischer, C
    Vollrath, B
    Mall, G
    Dietz, R
    Kubler, W
    Katus, HA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (02) : 475 - 482
  • [24] Structural analysis of the titin gene in hypertrophic cardiomyopathy: Identification of a novel disease gene
    Satoh, M
    Takahashi, M
    Sakamoto, T
    Hiroe, M
    Marumo, F
    Kimura, A
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 262 (02) : 411 - 417
  • [25] ALPHA-TROPOMYOSIN AND CARDIAC TROPONIN-T MUTATIONS CAUSE FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A DISEASE OF THE SARCOMERE
    THIERFELDER, L
    WATKINS, H
    MACRAE, C
    LAMAS, R
    MCKENNA, W
    VOSBERG, HP
    SEIDMAN, JG
    SEIDMAN, CE
    [J]. CELL, 1994, 77 (05) : 701 - 712
  • [26] HUMAN MYOSIN-BINDING PROTEIN-H (MYBP-H) - COMPLETE PRIMARY SEQUENCE, GENOMIC ORGANIZATION, AND CHROMOSOMAL LOCALIZATION
    VAUGHAN, KT
    WEBER, FE
    RIED, T
    WARD, DC
    REINACH, FC
    FISCHMAN, DA
    [J]. GENOMICS, 1993, 16 (01) : 34 - 40
  • [27] Mice expressing mutant myosin heavy chains are a model for familial hypertrophic cardiomyopathy
    Vikstrom, KL
    Factor, SM
    Leinwand, LA
    [J]. MOLECULAR MEDICINE, 1996, 2 (05) : 556 - 567
  • [28] MUTATIONS IN THE GENES FOR CARDIAC TROPONIN-T AND ALPHA-TROPOMYOSIN IN HYPERTROPHIC CARDIOMYOPATHY
    WATKINS, H
    MCKENNA, WJ
    THIERFELDER, L
    SUK, HJ
    ANAN, R
    ODONOGHUE, A
    SPIRITO, P
    MATSUMORI, A
    MORAVEC, CS
    SEIDMAN, JG
    SEIDMAN, CE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (16) : 1058 - 1064
  • [29] MUTATIONS IN THE CARDIAC MYOSIN BINDING PROTEIN-C GENE ON CHROMOSOME-11 CAUSE FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
    WATKINS, H
    CONNER, D
    THIERFELDER, L
    JARCHO, JA
    MACRAE, C
    MCKENNA, WJ
    MARON, BJ
    SEIDMAN, JG
    SEIDMAN, CE
    [J]. NATURE GENETICS, 1995, 11 (04) : 434 - 437
  • [30] NOVEL INSIGHTS INTO THE CLINICAL MANIFESTATIONS AND TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
    WIGLE, ED
    [J]. CURRENT OPINION IN CARDIOLOGY, 1995, 10 (03) : 299 - 305